Kantarci OH - Search Results

1

Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.

Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, Atkinson EJ, Siva A, Pittock SJ, Pirko I, Keegan BM, Lucchinetti CF, Noseworthy JH, Rodriguez M, Weinshenker BG, Kantarci OH. Tutuncu M, et al. Among authors: kantarci oh. Mult Scler. 2013 Feb;19(2):188-98. doi: 10.1177/1352458512451510. Epub 2012 Jun 26. Mult Scler. 2013. PMID: 22736750 Free PMC article.

2

Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG).

Kantarci O, Siva A, Eraksoy M, Karabudak R, Sütlaş N, Ağaoğlu J, Turan F, Ozmenoğlu M, Toğrul E, Demirkiran M. Kantarci O, et al. Neurology. 1998 Sep;51(3):765-72. doi: 10.1212/wnl.51.3.765. Neurology. 1998. PMID: 9748024

3

Seeking genes for MS: big risks for big gains.

Weinshenker BG, Kantarci OH. Weinshenker BG, et al. Among authors: kantarci oh. Neurology. 2000 Feb 8;54(3):542-4. doi: 10.1212/wnl.54.3.542. Neurology. 2000. PMID: 10680779 No abstract available.

4

Association of a myeloperoxidase promoter polymorphism with multiple sclerosis.

Kantarci OH, Atkinson EJ, Hebrink DD, McMurray CT, Weinshenker BG. Kantarci OH, et al. J Neuroimmunol. 2000 Jun 26;105(2):189-94. doi: 10.1016/s0165-5728(00)00198-3. J Neuroimmunol. 2000. PMID: 10742562

5

Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis.

Kantarci OH, Atkinson EJ, Hebrink DD, McMurray CT, Weinshenker BG. Kantarci OH, et al. J Neuroimmunol. 2000 Jul 1;106(1-2):220-7. doi: 10.1016/s0165-5728(00)00202-2. J Neuroimmunol. 2000. PMID: 10814801

6

A point mutation in PTPRC is associated with the development of multiple sclerosis.

Jacobsen M, Schweer D, Ziegler A, Gaber R, Schock S, Schwinzer R, Wonigeit K, Lindert RB, Kantarci O, Schaefer-Klein J, Schipper HI, Oertel WH, Heidenreich F, Weinshenker BG, Sommer N, Hemmer B. Jacobsen M, et al. Nat Genet. 2000 Dec;26(4):495-9. doi: 10.1038/82659. Nat Genet. 2000. PMID: 11101853

7

Association of a tumor necrosis factor alpha polymorphism with MS susceptibility.

Weinshenker BG, Hebrink DD, Atkinson E, Kantarci OH. Weinshenker BG, et al. Among authors: kantarci oh. Neurology. 2001 Oct 9;57(7):1341-2. doi: 10.1212/wnl.57.7.1341. Neurology. 2001. PMID: 11591866 No abstract available.

8

Genetic variation in the transforming growth factor beta1 gene in multiple sclerosis.

Weinshenker BG, Hebrink D, Kantarci OH, Schaefer-Klein J, Atkinson E, Schaid D, McMurray CM. Weinshenker BG, et al. Among authors: kantarci oh. J Neuroimmunol. 2001 Nov 1;120(1-2):138-45. doi: 10.1016/s0165-5728(01)00424-6. J Neuroimmunol. 2001. PMID: 11694328

9

Myeloperoxidase -463 (G-->A) polymorphism associated with lower risk of lung cancer.

Kantarci OH, Lesnick TG, Yang P, Meyer RL, Hebrink DD, McMurray CT, Weinshenker BG. Kantarci OH, et al. Mayo Clin Proc. 2002 Jan;77(1):17-22. doi: 10.4065/77.1.17. Mayo Clin Proc. 2002. PMID: 11794452

10

Identifying disease modifying genes in multiple sclerosis.

Kantarci OH, de Andrade M, Weinshenker BG. Kantarci OH, et al. J Neuroimmunol. 2002 Feb;123(1-2):144-59. doi: 10.1016/s0165-5728(01)00481-7. J Neuroimmunol. 2002. PMID: 11880159 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters